Health Care [ 4/12 ] | Biotechnology [ 18/72 ]
NASDAQ | Common Stock
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD).
Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.
The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure.
Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 17, 24 | -0.12 Decreased by -9.09% | -0.08 Decreased by -50.00% |
| Mar 28, 24 | -0.09 Increased by +25.00% | -0.09 |
| Nov 14, 23 | -0.09 Increased by +30.77% | -0.12 Increased by +25.00% |
| Aug 10, 23 | -0.12 Decreased by -20.00% | -0.12 |
| May 15, 23 | -0.11 Increased by +21.43% | -0.15 Increased by +26.67% |
| Mar 29, 23 | -0.12 Decreased by -9.09% | -0.15 Increased by +20.00% |
| Nov 10, 22 | -0.13 Increased by +27.66% | -0.14 Increased by +7.14% |
| Aug 10, 22 | -0.10 Increased by +37.50% | -0.15 Increased by +33.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -5.93 M Increased by +25.61% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -7.47 M Decreased by -15.14% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -7.09 M Increased by +20.83% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -7.52 M Decreased by -20.10% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -7.97 M Increased by +19.56% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by -100.00% | -6.49 M Increased by +1.09% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -8.95 M Decreased by -0.50% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -6.26 M Increased by +35.27% | Decreased by N/A% Decreased by N/A% |